Each of these new partnerships underscores MY01’s commitment to providing healthcare professionals with tools that can aid in accurate and timely diagnoses of compartment syndrome, helping to improve patient outcomes and reduce the risks associated with delayed diagnosis, such as unnecessary amputations or invasive procedures.*

Andrew Morris, Chief Commercial Officer at MY01, shared his excitement about the new partnerships: “At MY01, we are focused on transforming the way compartment syndrome is managed and learned. Expanding our reach through these distributor groups will allow us to help more patients, while eliminating physicians’ guesswork and giving them full control of their diagnosis.”

With the addition of these distributor groups – P2 Medical, Apex Medical, Select Medical, All Essential, Cade Surgical and Omni Orthopaedics – MY01 continues to expand its presence across key regions, bringing the benefits of continuous intracompartmental pressure monitoring to more healthcare facilities across the United States.

About MY01, Inc

Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, enabling precise, personalized care for all patients. Specializing in managing compartment syndrome, our tools provide proactive monitoring and actionable insights through a connected care team that benefits patients, providers, and payers. MY01 is commercial in the USA, Europe, and Canada, setting new standards in healthcare.

*Data presented at the Orthopedic Trauma Association Annual Meeting, Seattle, 2023. (ClinicalTrials.gov ID NCT04012723)